Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyInterventionalPublished in a peer-reviewed journal

Effects of a Low-Fat Diet on Fatigue and Metabolic Pathways in People with Multiple Sclerosis

In a 16-week study of 27 people with MS, those on a low-fat diet exhibited changes in fatigue scores correlated with shifts in lipid and amino acid pathways. Notably, certain lipids decreased in the intervention group while increasing in controls.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Demonstrated in people
Mechanism
Not reported
Evidence strength
Moderate
Outcome
Positive

Why it matters

These preliminary findings highlight the potential impact of dietary changes on metabolic processes related to fatigue in MS, suggesting a new avenue for exploration in managing symptoms.

What this does not prove

The small sample size and high variability among participants limit the reliability of these findings; larger, well-designed studies are necessary for confirmation.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Interventional
Participants / samples
27 · basis not reported
Randomised
Yes
Controlled
Yes
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-10-26
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
people with multiple sclerosis
Size of effect
Not reported
Secondary endpoints
dietary composition; adherence; body composition; cardiometabolic biomarkers
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (14)
study phaseMETHODS: This exploratory analysis used data from a 16-week, two-arm, randomized controlled trial in people with MS comparing a low-fat diet (intervention) with a waitlist (control) group that continued their usual diet.
study designMETHODS: This exploratory analysis used data from a 16-week, two-arm, randomized controlled trial in people with MS comparing a low-fat diet (intervention) with a waitlist (control) group that continued their usual diet.
subjectsWe investigated the effects of a low-fat diet on fatigue and serum metabolomic pathways in people with MS, focusing on lipid and amino-acid metabolism.
sample sizeRESULTS: Twenty-seven participants (16 intervention, 11 control) with complete data were included.
randomizedMETHODS: This exploratory analysis used data from a 16-week, two-arm, randomized controlled trial in people with MS comparing a low-fat diet (intervention) with a waitlist (control) group that continued their usual diet.
controlledMETHODS: This exploratory analysis used data from a 16-week, two-arm, randomized controlled trial in people with MS comparing a low-fat diet (intervention) with a waitlist (control) group that continued their usual diet.
findingsOf the 986 metabolites detected, changes in MFIS scores were correlated to shifts in fatty acid (e.g., octadecenedioylcarnitine, cis-4-decenoate) and amino acid (e.g., phenol sulfate, phenylpyruvate) pathways.
limitationsThe small sample size and inter-individual variability warrant cautious interpretation; replication in larger, adequately powered trials is needed.
populationWe investigated the effects of a low-fat diet on fatigue and serum metabolomic pathways in people with MS, focusing on lipid and amino-acid metabolism.
secondary endpointsAdditional outcomes included dietary composition, adherence, body composition, and cardiometabolic biomarkers.
outcomeThese preliminary exploratory findings suggest that diet-induced modulation of lipid and amino acid metabolism may contribute to fatigue changes.
human efficacyCONCLUSIONS: To our knowledge, this is the first study to explore the impact of a low-fat diet on serum metabolomic pathways in people with MS.
publication datePublication date: 2026-10-26
peer reviewedPublication types: Journal Article

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.